Pathfinder
Editor, Senior Moderator
<TABLE class=contentpaneopen><TBODY><TR><TD class=contentheading width="100%">Shantha launches Oral Vaccine against Cholera </TD><TD class=buttonheading align=right width="100%"> </TD><TD class=buttonheading align=right width="100%"></TD><TD class=buttonheading align=right width="100%"> </TD></TR></TBODY></TABLE><TABLE class=contentpaneopen><TBODY><TR><TD vAlign=top>Written by Admin </TD></TR><TR><TD class=createdate vAlign=top>Wednesday, 16 December 2009 01:00 </TD></TR><TR><TD vAlign=top><!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman";} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} .MsoPapDefault {mso-style-type:export-only; margin-bottom:10.0pt; line-height:115%;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} --><!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman";} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} .MsoPapDefault {mso-style-type:export-only; margin-bottom:10.0pt; line-height:115%;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} -->
Hyderabad: Breaking News!
Shantha, which was recently acquired by Sanofi Pasteur, has launched an oral vaccine against Cholera, which is the first of its kind in the country. The oral vaccine will be known as Shanchol.
The new vaccine can be administered to children in the age group of one to five. That will reduce the risk of developing cholera at the outbreak. It is expected to bring a new revolution in Indian medical history.
http://www.breakingnewsonline.net/health/91-cholera-oral-vaccine.html
The oral vaccine was developed in collaboration with the International Vaccine Institute (IVI), Seoul, Korea. It was tested on about 70,000 individuals in Kolkata.
http://www.breakingnewsonline.net/health/91-cholera-oral-vaccine.html
</TD></TR></TBODY></TABLE>
Hyderabad: Breaking News!
Shantha, which was recently acquired by Sanofi Pasteur, has launched an oral vaccine against Cholera, which is the first of its kind in the country. The oral vaccine will be known as Shanchol.
The new vaccine can be administered to children in the age group of one to five. That will reduce the risk of developing cholera at the outbreak. It is expected to bring a new revolution in Indian medical history.
http://www.breakingnewsonline.net/health/91-cholera-oral-vaccine.html
The oral vaccine was developed in collaboration with the International Vaccine Institute (IVI), Seoul, Korea. It was tested on about 70,000 individuals in Kolkata.
http://www.breakingnewsonline.net/health/91-cholera-oral-vaccine.html
</TD></TR></TBODY></TABLE>